Category: Clinical Considerations
Findings suggest COVID-19 rebound not caused by impaired immune response
NIH – Findings from a small study of eight patients published in Clinical Infectious Diseases suggest that COVID-19 rebound is likely not caused by impaired immune responses. The study, led by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, aimed to define the clinical course and the […]
Oct 6, 2022
Here’s what might happen the second—or third—time you get Covid, experts say: ‘There’s no guarantee’
CNBC – As the weather grows colder, you may find yourself experiencing a second — or even third — round of Covid infection. That prompts a few questions: Will getting Covid again be similar to my previous experience? Will it be any different than last time? Will my symptoms be more or less severe? The answer […]
Oct 6, 2022
Older patients more likely to report long-COVID symptoms
CIDRAP – Among patients seen at long-COVID clinics in four countries, older people were the most likely to report symptoms and have abnormal chest imaging and lung function tests, finds a study published late last week in the International Journal of Infectious Diseases. Researchers in Israel, Italy, Spain, and Switzerland followed 2,333 COVID-19 survivors for an average of […]
Oct 4, 2022
Long Covid Has Become a Parallel Pandemic
Bloomberg – There are millions of long-haulers in the US alone, and there will be millions more if we don’t develop better vaccines and treatments. The price of “living with Covid” in a free and open society is turning out to be much heftier than public health experts predicted. Even with good vaccines and treatments, […]
Oct 3, 2022
New Guidance Focuses on Long COVID in Kids
Med Page Today – When it comes to long COVID in children, physicians should focus on mitigating symptoms and encouraging multidisciplinary rehabilitation designed to improve age-appropriate development, according to new clinical guidance from the American Academy of Physical Medicine and Rehabilitation (AAPM&R). Long COVID can present differently in children, so standard practices for managing the […]
Sep 29, 2022
Study aims to understand how SARS-CoV-2 affects the brain long-term
Medical News – In addition to the lungs, COVID-19 also affects the central nervous system (CNS) through anoxic, viral neurotoxicity, inflammation, and cerebrovascular mechanisms. As a result, about one-third of COVID-19 patients develop different neurologic problems, such as seizures, loss of sense of smell or taste, and stroke. Related study in Translational Research and Clinical Interventions
Sep 29, 2022
CDC/IDSA Clinician Call: Updates & Emerging Issues on COVID-19 and Monkeypox
IDSA – Link to download slides Topic: Updates & Emerging Issues on COVID-19 and Monkeypox Moderator:Dana S. Wollins, DrPH, MGCVice President, Clinical Affairs & Practice Guidelines, IDSA Topics and Featured Experts COVID-19: Situation Update, Emerging Variants & Implications for Therapeutics:Pragna Patel, MD, MPHCaptain, U.S. Public Health ServiceChief Medical Officer (acting)Coronavirus and Other Respiratory Diseases Division […]
Sep 27, 2022
Covid-19 Associated With 72% Greater Risk Of Type 1 Diabetes Among Children, Study Shows
Forbes – Still think that getting Covid-19 is no big deal for children? Well, there’s been growing evidence that Covid-19 could hit you right in the pancreas. And a study just published as a research letter in JAMA Network furthered the possibility that Covid-19 may somehow lead to type 1 diabetes. Since type 1 diabetes results when the […]
Sep 27, 2022
Omicron subvariants linked to reinfections
CIDRAP – A new study based on COVID-19 patients in France shows high reinfection rates among people with different Omicron subvariants, including BA.1, BA.2, and BA.5. The study is published as a research letter in Emerging Infectious Diseases. The research group conducting this study, from Aix Marseille University, previously found reinfection rates were 6-fold higher during […]
Sep 27, 2022
A practical update on the management of patients with COVID–19
Royal College of Physicians – While vaccines against COVID-19 are being rolled out, an ongoing need remains for therapies to treat patients who have symptomatic COVID-19 before vaccination or in whom breakthrough infection develops. Dexamethasone and interleukin-6 inhibitors have been the mainstay of treatment for severe to critical COVID-19 requiring hospitalisation. However, in the previous […]
Sep 27, 2022